Sean Tucker
Founder bei VAXART, INC.
Vermögen: 541 086 $ am 31.03.2024
Profil
Sean N.
Tucker is the founder of Vaxart, Inc. which was founded in 2004.
He held the title of Director & Vice President-Research from 2012 to 2013.
He is currently the Chief Scientific Officer & Senior Vice President at Vaxart, Inc. Dr. Tucker also held former positions as Principal at The Dow Chemical Co., Systemix, Inc., and Genteric, Inc. In terms of education, Dr. Tucker obtained undergraduate and doctorate degrees from the University of Washington and a graduate degree from the University of California, Berkeley.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
VAXART, INC.
0,24% | 28.03.2024 | 416 220 ( 0,24% ) | 541 086 $ | 31.03.2024 |
Aktive Positionen von Sean Tucker
| Unternehmen | Position | Beginn |
|---|---|---|
| VAXART, INC. | Founder | 01.01.2004 |
Ehemalige bekannte Positionen von Sean Tucker
| Unternehmen | Position | Ende |
|---|---|---|
| DOW CHEMICAL COMPANY (THE) | Corporate Officer/Principal | - |
Genteric, Inc.
 Genteric, Inc. Pharmaceuticals: MajorHealth Technology Genteric, Inc. develops revolutionary therapeutic protein delivery technology. It is a biotech company formed to commercialize several proprietary technology platforms that harness the body's own protein production and distribution system. Genteric proprietary technology captures natural protein manufacturing capability for therapeutic benefit. The company is headquartered in Redwood City, CA. | Corporate Officer/Principal | - |
Systemix, Inc.
 Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Corporate Officer/Principal | - |
Vaxart, Inc. /Old/
 Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Founder | - |
Ausbildung von Sean Tucker
| University of Washington | Doctorate Degree |
| University of California, Berkeley | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| VAXART, INC. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
The Dow Chemical Co.
 The Dow Chemical Co. Chemicals: SpecialtyProcess Industries The Dow Chemical Co. engages in the manufacture and distribution of chemicals, plastics, industrial and agricultural products. It serves agriculture, automotive, building and construction, consumer, electronic materials, infrastructure, packaging, product finder and product safety industries. The company was founded by Herbert Henry Dow in 1897 and is headquartered in Midland, MI. | Process Industries |
Systemix, Inc.
Systemix, Inc. Medical/Nursing ServicesHealth Services Systemix, Inc. develops cell-based gene therapies for diseases. The company is based in Palo Alto, CA. The company was founded by Irving L. Weissman, Leroy E. Hood. Systemix was acquired by Novartis AG on February 14, 1997 for $75.90 million. | Health Services |
Vaxart, Inc. /Old/
Vaxart, Inc. /Old/ BiotechnologyHealth Technology Vaxart, Inc. develops technology for oral vaccination against infectious agents. Its products in pipeline include H1N1 seasonal influenza vaccine and oral H5N1 avian influenza vaccine. The firm develops oral recombinant vaccines based on its proprietary oral vaccine delivery platform. The company was founded by Sean N. Tucker in 2004 and is headquartered in San Francisco, CA. | Health Technology |
Genteric, Inc.
Genteric, Inc. Pharmaceuticals: MajorHealth Technology Genteric, Inc. develops revolutionary therapeutic protein delivery technology. It is a biotech company formed to commercialize several proprietary technology platforms that harness the body's own protein production and distribution system. Genteric proprietary technology captures natural protein manufacturing capability for therapeutic benefit. The company is headquartered in Redwood City, CA. | Health Technology |
